Project Details
Description
The Joint Master Degree entitled ¿Leading International Vaccinology Education¿ (LIVE +) is a Master of Science in Biomedical Sciences with socio-economic sciences and humanities, delivering 120 European Credit Transfer System with an emphasis on employability of the graduated international students and dedicated to train the next generation of vaccinologists to fill a gap in global post-graduate formation. LIVE is jointly delivered by 5 leading European Higher Education Institutions (HEIs), namely Université Claude Bernard Lyon 1 and Université Jean Monnet Saint-Etienne (FR), Universitat Autònoma de Barcelona and Universitat de Barcelona (ES), and University of Antwerp (BE), in agreement and close collaboration with 45 associate partners (AP) from the whole world of chain in Vaccinology: HEIs, foundations, organisations, small and medium size and big pharma companies, and clinical or research centres in Vaccinology, worldwide. Pre-requisite: motivated Biochemists, Bioengineers, Biologists, Physicians, Pharmacists or Veterinary applicants have a bachelor level (180 ECTS) in cell biology, molecular biology, biochemistry and basic immunology to enter in LIVE.
Students move from Barcelona (S1), to Antwerp (S2), then Lyon (S3). Before moving worldwide for their Master thesis (S4), they are deeply trained in (1) Immunology, Immunopathology, (2) Infectiology, Epidemiology, (3) Research, Clinical and Industrial Vaccinology, (4) multidisciplinary aspects: Public Health, Communication, Project Management, Confidence in Vaccination, Ethics and Languages. During S2 and S3, they attend an international Summer School on vaccinology, and participate to yearly visits at industrial partners¿ sites. At S3 being involved in Massive Open Online Course development, as part of their official training, they experience innovative educational practice. S4 is dedicated to internships and Master thesis, co-supervised by all universities.
Acronym | LIVE+ |
---|---|
Status | Active |
Effective start/end date | 3/09/18 → 2/09/24 |
Collaborative partners
- Vaccine Formulation Institute Ltd.
- Centre National de la Recherche Scientifique (CNRS)
- Universitat de Barcelona (UB)
- Bioaster Fondation de Cooperation Scientifique
- bioMérieux España
- University of Florence
- Commissariat à l'énergie atomique et aux énergies alternatives
- Vrije Universiteit Brussel (Free University of Brussels - VUB)
- Fondation Mérieux
- Merieux Alliance S.A.
- Vakzine Projekt Management GmbH
- Fudan University
- Instituto Butantan
- Institut National de la Santé et de la Recherche Médicale
- Association Lyon Biopole
- Claude Bernard University Lyon 1 (UCBL) (lead)
- Université Paris XII - Val de Marne
- Statens Serum Institut
- Barcelona Institute for Global Health (ISGlobal)
- University of São Paulo (USP)
- Antwerp University
- Universite Jean Monnet Saint Etienne
- Centre Nacional de Recherche Scientifique et Technologique Burkina Faso
- Merial SAS
- Ecole Normale Supérieure de Lyon (ENS de Lyon)
- Fondation Health Sciences e-Training
- Pfizer Manufacturing Deutschland GmbH
- Pirbright Institut
- Bundesinstitut für Impfstoffe und Biomedizinische Arzneimittel (Paul-Ehrlich-Institut)
- Valneva SE
- Etablissement Français du Sang
- Amal Therapeutics
- Sanofi Pasteur MSD, SA
- Immuno Valley
- Centre Muraz
- European Vaccine Initiative
- Transgene S.A.
- Universidad de Oriente
- Centre Pasteur du Camerun
- International Vaccine Institute
- Takeda Pharmaceuticals Internacional AG
- GlaxoSmithKline Biologicals
- University of Arkansas for Medical Sciences
- University of British Columbia
- Universitat Autònoma de Barcelona (UAB)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.